Liver Diseases

• 

  Subject Areas on Research

  • A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function. 
  • A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. 
  • A Summary of The 6th International Conference on Coagulation in Liver Disease: Discussion, Debate, Deliberations. 
  • A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial. 
  • A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. 
  • A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. 
  • A spectrum of severe familial liver disorders associate with telomerase mutations. 
  • AASLD Deepens Commitment to Diversity, Equity, and Inclusion. 
  • Abdominal-gastrointestinal radiology. 
  • Access to technology to support telehealth in areas without specialty care for liver disease. 
  • Acquired functional asplenia. Association with spontaneous rupture of the spleen and fatal spontaneous rupture of the liver in amyloidosis. 
  • Acting in the face of uncertainty. 
  • Acute Hepatic Failure and Nutrition. 
  • Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action. 
  • Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver. 
  • Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. 
  • Alpha-1-antitrypsin globules in hepatocytes of elderly persons with liver disease. 
  • Amiodarone hepatotoxicity simulating alcoholic liver disease. 
  • An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. 
  • Are hepatic and muscle T2 values different at 0.5 and 1.5 Tesla? 
  • Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration. 
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. 
  • Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index. 
  • Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. 
  • Bleeding and thrombotic complications of pediatric liver transplant. 
  • Bone marrow transplantation in patients aged 45 years and older. 
  • COVID-19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action. 
  • Calcified hepatic arteriovenous fistula found after biopsy of the liver: unusual cause of calcification in the right upper quadrant. 
  • Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. 
  • Can virtual monochromatic images from dual-energy CT replace low-kVp images for abdominal contrast-enhanced CT in small- and medium-sized patients? 
  • Cardiohepatic interactions in heart failure: an overview and clinical implications. 
  • Cases from the Osler Medical Service at Johns Hopkins University. 
  • Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis. 
  • Changes in the management of benign liver tumours: an analysis of 285 patients. 
  • Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2-/- mouse model. 
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. 
  • Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. 
  • Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation. 
  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. 
  • Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy. 
  • Clinical and physiological abnormalities in hepatic function. 
  • Clinical features of scrub typhus. 
  • Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. 
  • Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. 
  • Coagulation in Liver Disease. 
  • Combined hepatocellular and cystadenocarcinoma presenting as a giant cyst of the liver--a case report. 
  • Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782). 
  • Commentary on "Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis". 
  • Comparison of intestinal lengthening procedures for patients with short bowel syndrome. 
  • Competing Mortality in Patients With Neuroendocrine Tumors. 
  • Complementary and Alternative Medicine Use in United States Adults With Liver Disease. 
  • Complications of human immunodeficiency virus therapy. 
  • Computed tomography: revolutionizing the practice of medicine for 40 years. 
  • Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 3: Focus on Cardiorespiratory Dysfunction, Infections, Liver Dysfunction, and Delirium. 
  • Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. 
  • Coronary artery disease and liver transplantation: the state of the art. 
  • Covert hepatic encephalopathy: not as minimal as you might think. 
  • Critical mitral stenosis causing ischemic hepatic failure. Successful treatment by percutaneous balloon mitral valvotomy. 
  • Current status of hepatic resection. 
  • Cyst of the falciform ligament of the liver. 
  • Cystic disease of liver and kidney with portal hypertension. A cause of sudden unexpected hematemesis. 
  • Cytokine regulation of liver injury and repair. 
  • Cytomegalovirus infection in the normal host. 
  • DIfferential Subsampling With Cartesian Ordering With Respiratory Triggering Versus Conventional Liver Acquisition With Volume Acquisition: A Multiple Reader Preference Study. 
  • Deep Learning Algorithm for Automated Segmentation and Volume Measurement of the Liver and Spleen Using Portal Venous Phase Computed Tomography Images. 
  • Deep convolutional neural network applied to the liver imaging reporting and data system (LI-RADS) version 2014 category classification: a pilot study. 
  • Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. 
  • Determinants of the severity of fatty liver diseases: Need all the pieces to solve the puzzle. 
  • Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows. 
  • Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group. 
  • Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. 
  • Disseminated intravascular coagulation (DIC): an approach. 
  • Disseminated intravascular coagulation: a reappraisal. 
  • Distinctive clinical features of portopulmonary hypertension. 
  • Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. 
  • Du Pont aca and Dow AST/ALT-UV (PLP activated)-centrifugal analyzer serum aspartate aminotransferase assays compare well. 
  • Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. 
  • Echogenic polymer coating: does it improve needle visualization in sonographically guided biopsy? 
  • Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. 
  • Enterococcus faecalis causing empyema in a patient with liver disease. 
  • Epidural analgesia in hepatic resection. 
  • Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health. 
  • Examining reoperation and readmission after hepatic surgery. 
  • Extracardiac Abnormalities of Preload Reserve: Mechanisms Underlying Exercise Limitation in Heart Failure with Preserved Ejection Fraction, Autonomic Dysfunction, and Liver Disease. 
  • Extracorporeal liver support for trauma-induced hepatic dysfunction. 
  • Fibropolycystic liver disease: CT and MR imaging findings. 
  • Fine needle aspiration biopsy of the liver. 
  • Fine-needle aspiration of the liver and pancreas: a cytology primer for radiologists. 
  • Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 
  • Focal liver lesions hyperintense on T1-weighted magnetic resonance images. 
  • Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. 
  • Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. 
  • Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma. 
  • Geographic favoritism in liver transplantation--unfortunate or unfair? 
  • Geographic favoritism in liver transplantation. 
  • Gestational Alloimmune Liver Disease: A Case Study. 
  • Glycogenic Hepatopathy Causing Elevated Lactic Acid and Liver Enzymes. 
  • Gray scale ultrasound and isotope scanning: complementary techniques for imaging the liver. 
  • Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection. 
  • Hedgehog signaling in cholangiocytes. 
  • Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. 
  • Hedgehog signalling in liver pathophysiology. 
  • Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation. 
  • Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? 
  • Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide. 
  • Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. 
  • Hepatic biloma complicating sickle cell disease. A case report and a review of the literature. 
  • Hepatic candidiasis: persistent pyrexia in a patient with acute myeloid leukaemia after recovery from consolidation therapy-induced neutropenia. 
  • Hepatic complications of obesity. 
  • Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. 
  • Hepatic failure in adult Niemann-Pick disease. 
  • Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? 
  • Hepatic iron overload: diagnosis and quantification by noninvasive imaging. 
  • Hepatic parenchymal transection with vascular staplers: a comparative analysis with the crush-clamp technique. 
  • Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver. 
  • Hepatic uterus-like mass misdiagnosed as hepatic abscess. 
  • Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. 
  • Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? 
  • Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. 
  • Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets. 
  • Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. 
  • Hypercalcemia. A complication of advanced chronic liver disease. 
  • Hypercoagulation and thrombophilia in liver disease. 
  • Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic Correlation. 
  • Imaging approach for evaluation of focal liver lesions. 
  • Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). 
  • Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. 
  • Increased hepatic oxygenation following ethanol administration in the baboon. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. 
  • Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. 
  • Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. 
  • Intestinal and hepatic complications of human bone marrow transplantation. Part I. 
  • Intestinal and hepatic complications of human bone marrow transplantation. Part II. 
  • Iron overload following red blood cell transfusion and its impact on disease severity. 
  • Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? 
  • Kupffer cell-derived Fas ligand plays a role in liver injury and hepatocyte death. 
  • Laparoscopic vs open right hepatectomy: a value-based analysis. 
  • Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? 
  • Liver biopsy. 
  • Liver disease in menopause. 
  • Liver disease in pregnancy. 
  • Liver disease in pregnancy. 
  • Liver disease in pregnancy. 
  • Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. 
  • Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver hypoxia as a trigger to liver regeneration: No more than another piece of the puzzle. 
  • Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5. 
  • Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis. 
  • Liver retransplantation: the University of Wisconsin experience. 
  • Liver transplantation at the University of Wisconsin. 
  • Liver transplantation for HELLP syndrome. 
  • Liver transplantation for glycogen storage disease types I, III, and IV. 
  • Liver transplantation in alcoholics: assessment of psychological health and work activity. 
  • Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors. 
  • Local access to subspecialty care influences the chance of receiving a liver transplant. 
  • Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial. 
  • Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. 
  • Long-term management of the liver transplant patient: recommendations for the primary care doctor. 
  • Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice. 
  • MR Imaging of Diffuse Liver Disease. 
  • MR of focal liver lesions: comparison of breath-hold and non-breath-hold hybrid RARE and conventional spin-echo T2-weighted pulse sequences. 
  • Magnetic resonance contrast agents for liver imaging. 
  • Magnetic resonance imaging and hepatic hemodynamics: correlation with metabolic function in liver transplantation candidates. 
  • Magnetic resonance imaging-derived parameter of portal flow predicts volume-mediated pulmonary hypertension in liver transplantation candidates. 
  • Magnetic resonance microscopy and histopathology: comparative approach of bromobenzene-induced hepatotoxicity in the rat. 
  • Malfunction of the liver after transplantation: an analysis of potential risk factors. 
  • Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. 
  • Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. 
  • Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage. 
  • Medical problems occurring after orthotopic liver transplantation. 
  • Meningococcemia and acquired complement deficiency. Association in patients with hepatic failure. 
  • Mitigation of pennyroyal oil hepatotoxicity in the mouse. 
  • Multidetector helical computed tomography of the liver: comparison of hepatic enhancement using two different contrast media strategies. 
  • Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose? 
  • NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. 
  • Natural history of liver imaging reporting and data system category 4 nodules in MRI. 
  • Negative Biopsy of Focal Hepatic Lesions: Decision Tree Model for Patient Management. 
  • Neighborhood watch orchestrates liver regeneration. 
  • Nephrotoxicity and hepatotoxicity induced by inhaled bromodichloromethane in wild-type and p53-heterozygous mice. 
  • Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. 
  • Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. 
  • Noninvasive tools to assess liver disease. 
  • Noninvasive tools to assess liver disease. 
  • Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. 
  • Nrf2, a multi-organ protector? 
  • Nucleic acid-binding polymers as anti-inflammatory agents. 
  • Obstructive and perforative colonic carcinoma: patterns of failure. 
  • Orthotopic liver transplantation in patients 60 years of age and older. 
  • Partial hepatectomy and bile duct ligation in rainbow trout (Oncorhynchus mykiss): histologic, immunohistochemical and enzyme histochemical characterization of hepatic regeneration and biliary hyperplasia. 
  • Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. 
  • Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis. 
  • Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration. 
  • Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease. 
  • Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. 
  • Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection. 
  • Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. 
  • Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches. 
  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. 
  • Portal hypertension and granulomatous liver disease in a lung transplant recipient due to disseminated atypical mycobacterial infection. 
  • Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. 
  • Portopulmonary hypertension and the liver transplant candidate. 
  • Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 
  • Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. 
  • Preliminary experience with split liver transplantation. 
  • Preoperative delta-MELD score does not independently predict mortality after liver transplantation. 
  • Preoperative vascular imaging in pediatric liver transplantation. 
  • Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. 
  • Primary Hepatic Lymphoma Complicated by a Hepatic Inflammatory Pseudotumor and Tumor-Forming Pancreatitis. 
  • Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia. 
  • Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. 
  • Progressive hepatic injury in prolonged parenteral alimentation. 
  • Pushing the frontiers of operative treatment of hydatid liver disease a step forward. 
  • Quantitative Features of Liver Lesions, Lung Nodules, and Renal Stones at Multi-Detector Row CT Examinations: Dependency on Radiation Dose and Reconstruction Algorithm. 
  • Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease. 
  • Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19. 
  • Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. 
  • Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. 
  • Reduced transfusion requirements during major hepatic resection with use of intraoperative isovolemic hemodilution. 
  • Regenerative hepatic pseudotumor: a new pseudotumor of the liver. 
  • Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. 
  • Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. 
  • Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? 
  • Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): smoking and chronic liver disease are predictors of protection against PEP. 
  • Robotic Liver Resection: A Case-Matched Comparison. 
  • Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis. 
  • Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. 
  • Role of coronary artery calcium score in identifying occult coronary artery disease in patients evaluated for deceased-donor liver transplant - a preliminary report. 
  • Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease. 
  • Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. 
  • Safety considerations with niacin therapy. 
  • Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis. 
  • Sarcoidosis of the uterus. 
  • Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise? 
  • Scintigraphy, ultrasound and CT scanning of the liver. 
  • Segment IV liver cyst with biliary communication following laparoscopic deroofing. 
  • Serum aminotransferase changes with significant weight loss: sex and age effects. 
  • Serum angiotensin converting enzyme activity in evaluation of patients with liver disease. 
  • Signals from dying hepatocytes trigger growth of liver progenitors. 
  • Simulation of liver lesions for pediatric CT. 
  • Single photon emission computed tomography (SPECT). Part II: Clinical applications. 
  • Single-center experience of transplantation for polycystic liver disease. 
  • Single-incision laparoscopic liver resection. 
  • Society of pediatric liver transplantation: Current registry status 2011-2018. 
  • Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Some effects of imidocarb in goats. 
  • Spectrum of Pitfalls, Pseudolesions, and Misdiagnoses in Noncirrhotic Liver. 
  • Spindle-cell lesions of the liver: diagnosis by fine-needle aspiration biopsy. 
  • Splenic venous flow exceeding portal venous flow at Doppler sonography: relationship to portosystemic varices. 
  • Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI. 
  • Statin safety: an assessment using an administrative claims database. 
  • Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging. 
  • Surgical clearance for the patient with chronic liver disease. 
  • Surgical resection for benign and malignant liver disease. 
  • Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. 
  • Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. 
  • T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI. 
  • Technique for MR imaging of the liver. 
  • Techniques for computed tomography of the liver. 
  • Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States. 
  • The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis. 
  • The accuracy of pre-operative imaging in the management of hepatic cysts. 
  • The current status of living donor liver transplantation. 
  • The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. 
  • The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. 
  • The impact of hepatic pressurization on liver shear wave speed estimates in constrained versus unconstrained conditions. 
  • The impact of post-transplant diabetes mellitus on liver transplant outcomes. 
  • The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. 
  • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. 
  • The role of Hedgehog signaling in fibrogenic liver repair. 
  • The role of Smad3 in mediating mouse hepatic stellate cell activation. 
  • The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue? 
  • The role of donor-specific HLA alloantibodies in liver transplantation. 
  • The use of complementary and alternative medicine by patients with chronic hepatitis C. 
  • Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism. 
  • Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Critical Illness and Heart, Kidney, and Liver Diseases. 
  • Total parenteral nutrition. 
  • Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism. 
  • Transverse hepatectomy for symptomatic polycystic liver disease. 
  • Treatment considerations for patients with neuropathic pain and other medical comorbidities. 
  • USE OF TANNED COLLAGEN SPONGES IN THE TREATMENT OF LIVER INJURIES. 
  • Underlying potential: cellular and molecular determinants of adult liver repair. 
  • Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. 
  • Using outcomes data to identify best medical practice: the role of policy models. 
  • Volume-mediated pulmonary responses in liver transplant candidates. 
  • What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons? 
  • What's new in gastrointestinal and hepatobiliary surgery. 
  • [Idiophatic inflammatory myophaties: its asociation with liver disorders]. 
• 

  Keywords of People

  • Amin, Mansi D, Assistant Professor of Pediatrics, Pediatrics, Gastroenterology, Hepatology and Nutrition
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology
  • Freemark, Michael Scott, Robert C. Atkins, M.D. and Veronica Atkins Distinguished Professor of Pediatrics, in the School of Medicine, Pediatrics, Endocrinology
  • Muir, Andrew Joseph, Professor of Medicine, Duke Innovation & Entrepreneurship
  • Townsend, Matthew, House Staff, Medicine